Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 90,712 | 156,184 | 163,209 | 221,878 | 156,091 |
Receivables | 573 | 4,934 | 3,712 | 10,602 | 5,556 |
Inventories | N/A | 9,502 | 10,831 | 12,759 | 6,058 |
Other current assets | 26,435 | 0 | 0 | 0 | 0 |
TOTAL | $119,889 | $174,838 | $181,896 | $248,810 | $171,159 |
Non-Current Assets | |||||
PPE Net | 35,109 | 71,828 | 82,919 | 77,388 | 75,417 |
Intangibles | 0 | 7,775 | 8,482 | 10,182 | 10,611 |
Other Non-Current Assets | 14,012 | 2,351 | 3,088 | 3,427 | 4,019 |
TOTAL | $49,121 | $81,954 | $94,489 | $90,997 | $90,047 |
Total Assets | $169,010 | $256,792 | $276,385 | $339,807 | $261,206 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 5,676 | 22,207 | 42,131 | 29,510 | 7,123 |
Accrued Expenses | 3,883 | 3,286 | 7,027 | 1,317 | 3,087 |
Other current liabilities | 46,392 | N/A | 474 | 0 | 2,587 |
TOTAL | $63,879 | $49,896 | $67,362 | $70,744 | $29,914 |
Non-Current Liabilities | |||||
Deferred Revenues | 4,410 | 21,425 | 15,238 | 37,861 | 15,453 |
Other Non-Current Liabilities | 1,201 | 470 | 0 | 4,892 | 12,455 |
TOTAL | $64,736 | $153,354 | $161,678 | $177,206 | $132,653 |
Total Liabilities | $128,615 | $203,250 | $229,040 | $247,950 | $162,567 |
Shareholders' Equity | |||||
Shares Outstanding, K | 24,547 | 24,287 | 24,146 | 21,926 | 21,749 |
Common Shares | 2 | 24 | 22 | 22 | 22 |
Retained earnings | -1,398,736 | -1,376,220 | -1,268,241 | -1,207,733 | -1,188,298 |
Other shareholders' equity | -2,608 | -1,179 | 2,908 | 5,728 | 5,489 |
TOTAL | $40,395 | $53,542 | $47,345 | $91,857 | $98,639 |
Total Liabilities And Equity | $169,010 | $256,792 | $276,385 | $339,807 | $261,206 |